wsha day 1 bridget final for handout · 2019. 10. 9. · chemotherapy radiation therapy - as...
TRANSCRIPT
WSHA 2019
1
Best Practice for Communication and Swallowing: Hope for Head and Neck Cancer Survivors
Introduction to Head and Neck CancerWYOMING SPEECH-LANGUAGE-HEARING ASSOCIATION CONVENTIONOCTOBER 10, 2019BRIDGET GUENTHER, MS, CCC-SLP, BCS-S
Disclosures Financial Disclosure: ◦ Ms. Guenther is employed by Atos Medical, Inc. and Atos
Medical paid for her travel to present at the conference
Non Financial Disclosure: ◦ Ms. Guenther is a member of the following organizations: ◦ American Speech Language and Hearing Association (ASHA)◦ American Board of Swallowing and Swallowing Disorders (AB-
SSD))◦ Dysphagia Research Society (DRS)◦ New Mexico Speech Language and Hearing Association
(NMSHA)
Overview of our 2 day journey
Thursday, October 10◦ Intro to HNC (Bridget)◦ Evaluation of Dysphagia in HNC patients
(Melissa)◦ Intro to Lymphedema (Joy)◦ Application of Knowledge, Case Studies
and Panel discussion (All)
Friday, October 11◦ Intro to Treatment of Total
Laryngectomee (Bridget)◦ Treatment of Dysphagia in HNC patients
(Melissa)◦ Treatment of Lymphedema (Joy)◦ Application of Knowledge, Case Studies
and Panel discussion (All)
GOAL: To improve knowledge surrounding the care of patients with head and neck cancer to improve lives and treatment outcomes
1
2
3
WSHA 2019
2
Objectives (Additional to the ones listed on course outcomes)
After this section, participants will be able to:
List 3 causes of Head and Neck Cancer (HNC)
Describe differences in incidence of Oropharyngeal, Pharyngeal, and Laryngeal cancers
Identify 3 different treatment options for HNC
Explain the importance of incorporating Quality of Life (QOL) in evaluation and treatment of patients with HNC
OVERVIEWHead and Neck Cancers
Treatment Options
Deficits by Cancer Site
Interdisciplinary HNC Care Team
SLP Scope and Role
Quality of Life (QoL)
Laryngectomy◦ Anatomical Changes◦ PreOp Evaluation and Counseling
5
“Head and neck cancer strikes at the most basic human functions-the ability to communicate, eat, and interact socially”Assessing quality of life in head and neck cancer.Gotay CC, Moore TD.Qual Life Res. 1992 Feb;1(1):5-17
4
5
6
WSHA 2019
3
Head and Neck CancerIncidence vs. PrevalenceStatisticsSymptomsLocation
7
Image approved for reuse by Atos Medical, Inc.
Incidence vs. PrevalenceINCIDENCE
RISK OF CONTRACTING CANCER
or
A PERSON’S PROBABILITY OF BEING DIAGNOSED
or
THE NUMBER OF NEWLY DIAGNOSED CASES
PREVALENCE HOW WIDESPREAD CANCER
IS
or
NUMBER OF CASES EXISTING IN A POPULATION DIVIDED BY
THE POPULATION.
Source: https://www.health.ny.gov/diseases/chronic/basicstat.htm
INCIDENCEHead and neck cancer accounts for about 4% of all cancers in the US
Risk of oral cavity/pharynx cancer: 1.2% (2014-2016 data)Risk of laryngeal cancer: 0.3% (2014-2016 data)
PREVALENCE ALL HEAD & NECK CANCERS2019 (Estimates): ◦ 65,410 adults diagnosed (4%
of all cancers) ◦ 14,620 deaths (1.6% of all
cancer deaths)◦ 3:1 men:women for
diagnosis and deaths
Source: https://www.cancer.net/cancer-types/head-and-neck-cancer/statistics
Image labeled for reuse https://commons.wikimedia.org/wiki/File:Diagram_showing_the_parts_of_the_pharynx_CRUK_334.svg )
7
8
9
WSHA 2019
4
WYOMING INCIDENCE
Source: www.seer.gov (information available by state)
Change in Cancer INCIDENCE – WYOMING 2013-2019Source: www.seer.gov (information available by state)
SURVIVAL
5 YEAR OVERALL SURVIVAL RATESIncludes ALL stages (Stage I through Stage IV)(2009-2014) Latest Data
Oral Cavity: ◦65.3%
Larynx: ◦60.3%
Images purchased from iStock
Source: https://www.cancer.net/cancer-types/head-and-neck-cancer/statistics
10
11
12
WSHA 2019
5
But not all SURVIVAL RATES ARE EQUAL…
13
Larynx Cancer example
Source: https://seer.cancer.gov/statfacts/html/laryn.html
General Trends across the US From Epidemiological Trends of Head and Neck
Cancer in the United States: A SEER Population Study (2017)
From 2002-2012: 149,301 cases of HNC Overall rate decreased by 0.22% per year Rate of laryngeal cancer decreased by 1.9% per year Rate of oropharyngeal (HPV-related) cancer increased
by 2.5% per year HNC rates: increased significantly in Kentucky and Connecticut decreased in California HPV-related cancers increased significantly in all states
except Georgia, Hawaii, and Michigan Laryngeal cancer rates decreased in California,
Georgia, New Jersey, and New Mexico
14
Mourad, M., Jetmore, T., Jategaonkar, A. A., Moubayed, S., Moshier, E., & Urken, M. L. (2017). Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 75(12), 2562–2572. doi:10.1016/j.joms.2017.05.008
General Trends across the US (cont’d) From Epidemiological Trends of Head and
Neck Cancer in the United States: A SEER Population Study (2017)
From 2002-2012: Conclusion: ◦Overall incidence of HNC is decreasing in the US
◦ Increasing incidence of HPV-related cancers of the oropharynx
◦Overall increase in HPV-related cancer in patients older than 50 years.
15
Mourad, M., Jetmore, T., Jategaonkar, A. A., Moubayed, S., Moshier, E., & Urken, M. L. (2017). Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 75(12), 2562–2572. doi:10.1016/j.joms.2017.05.008
13
14
15
WSHA 2019
6
CausesSmoking / DrinkingHerbal useViral (HPV, EBV)Environmental exposureRole of Genetics?Unknown
Symptoms
A lump in the neck Change in voice A growth in the mouth Bringing up blood Swallowing problems Changes in the skin Persistent earache
17Images labeled for reuse: https://tinyurl.com/y2duln93https://tinyurl.com/y2sgdlz3
Location of Head and Neck Cancers
Anywhere in the head or neck:◦Nasopharynx, sinus and nasal cavity◦Oral / Oropharyngeal◦Larynx / Hypopharynx◦Salivary glands◦Lymph nodes (Locoregional metastasis)NOT …. Thyroid, Blood Cancers, Skin Cancers
18
16
17
18
WSHA 2019
7
Location of HNC by site
Approximate distribution of head and neck cancer:
Oral cavity, 44%; Larynx, 31%; andPharynx, 25%
Image: labeled for reuse: https://tinyurl.com/y6r8xrq7
https://oncologypro.esmo.org/content/download/113133/1971849/file/2017-ESMO-Essentials-for-Clinicians-Head-Neck-Cancers-Chapter-1.pdf
Let’s take a look at some images of Head and Neck Cancer
Staging(and why should the SLP care?)
What is staging?How is Head and Neck Cancer staged?
T= TumorN= NodesM= Metastasis
24Image: Labeled for Reuse https://commons.wikimedia.org/wiki/File:Cervical_lymph_nodes_and_levels.png
19
20
24
WSHA 2019
8
AJCC and NCCNAmerican Joint Committee on Cancer (AJCC) staging system, 8th Edition (2018)Drives staging decisionsMost recent edition with considerations to the differences of
HPV+ and HPV- Cancers
National Comprehensive Cancer Network (NCCN) Guidelines then drive treatment protocol recommendations based on staging Sign up for Free Account to view the recommendations by
NCCN GuidelinesHead and Neck Cancer last updated 9/2019https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Why SLPs should care about staging
Predicted survival is related to site of cancer, staging, HPV status, and other clinical and pathologic factorsPatient presentation and function is direct correlate of stagingTreatment is driven by staging and acute toxicity increases as treatment protocols escalate
Inability to eatresults in loss of muscle mass and malnutrition (reduced functional reserves)
Results in worsening dysphagia (the role of prophylactic swallowing treatment and remember best exercise for eating is eating)
Pain can be overwhelmingreduced ability to f/through on treatment protocols/PO intake
Reduced PO intake and hydration
Mental Health is impactedimpaired ability to participate in decision making/go to appointments
Staging combined with evaluation, in depth interviewing, and patient reported surveys/outcome measures drives treatment
So the patient has a cancer staging…now to cancer treatment decision making
25
28
29
WSHA 2019
9
Treatment OptionsChemotherapyRadiation Therapy
- As treatment option (for cure or control)- Post surgical protocol (planned or (+) surgical margins)Surgical Intervention
- As treatment (for cure)- As Pre radiation protocolCombination of ChemoRadiation (CRT) +/- SurgeryNo treatment as a decisionInnovations in Treatment
30
ChemotherapyThree primary roles:◦Neoadjuvant or induction chemotherapy before locoregional treatment with surgery or radiation◦Concurrent chemotherapy and radiotherapy for advanced disease◦Adjuvant post-op chemotherapy usually with radiation
31
Side EffectsXerostomia MucositisDysgeusia (Change in taste)Nausea / Vomiting Generalized weakness and fatigue Dysphagia / Odynophagia / Loss of AppetiteHair LossHearing Loss
32
Lalla, R. V., Sonis, S. T., & Peterson, D. E. (2008). Management of oral mucositis in patients who have cancer.Dental clinics of North America, 52(1), 61–viii. doi:10.1016/j.cden.2007.10.002Groher M.E. & Crary, M.A. (2010) Dysphagia: Clinical management in adults and children. Mosby/Elsevier Press. Maryland Heights MO
30
31
32
WSHA 2019
10
Otologic Effects of ChemoPrimary drugs for H&N Ca that are ototoxic are -platin drugs (Cisplatin, Carboplatin)Higher dose given less often = greater chance of ototoxicityResults in high frequency lossCase for monitoring to establish baseline, during treatment, and again post treatment
33
Radiotherapy aka Radiation Therapy or RT or XRT
Three primary roles:◦Post-operative radiotherapy (RT)◦Definitive RT (for Cure)◦Combined Modality = Chemoradiation therapy (CRT)
34
Radiation Therapy Uses highly charged ionizing particles
that interact with cells Traditional and IMRT are daily (M-F) for
up to 7 weeks varies based on STAGING
Technological advances related to focus of radiation include higher dosing but less frequent treatment (IMRT) or Proton
Often require pre-xrt extractions / repair of those teeth that are in the radiation field (may try to keep Maxillary teeth but many get osteoradionecrosis)
35Image Labeled for Reuse https://commons.wikimedia.org/wiki/File:RT_Mask_Oropharyngeal_cancer.jpg
33
34
35
WSHA 2019
11
https://www.youtube.com/watch?v=W_ClcBF6a0IEXAMPLE OF RADIATION THERAPY
36
Side EffectsSHORT TERM
(ACUTE/SUBACUTE)Redness / Burns / Skin reactionsLymphedemaIrritation
Sores in the mouthXerostomia (dry mouth)Thickened saliva and other secretions (such as cerumen)DysphagiaChanges in or loss of tastePain, infectionMucositis
LONG TERM (CHRONIC/LATE)
DysphagiaLymphedemaTrismus
Nerve Damage (resulting in weakness, discoordination, reduced ROM) (Peripheral Neuropathy)Mild to Severe Organ DysfunctionCarotid Artery Occlusion
HypothyroidismFibrosis
37
Lalla, R. V., Sonis, S. T., & Peterson, D. E. (2008). Management of oral mucositis in patients who have cancer.Dental clinics of North America, 52(1), 61–viii. doi:10.1016/j.cden.2007.10.002 and Groher M.E. & Crary, M.A. (2010) Dysphagia: Clinical management in adults and children. Mosby/Elsevier Press. Maryland Heights, MO.
Otologic Effects of XRT
May result in conductive, sensorineural or mixed hearing loss Up to 40% of patients have acute middle ear side effects during xrt that includes acoustic structures (in the field); 33% develop late SNHL (Jereczek-Fossa et al, 2003)Effect depends on xrt dosage and tumor location
39
Jereczek-Fossa, Barbara A et al. Radiotherapy-induced ear toxicity Cancer Treatment Reviews, Volume 29, Issue 5, 417 – 430
Bhandare, N., Jackson, A., Eisbruch, A., Pan, C. C., Flickinger, J. C., Antonelli, P., & Mendenhall, W. M. (2010). Radiation therapy and hearing loss. International journal of radiation oncology, biology, physics, 76(3 Suppl), S50–S57. doi:10.1016/j.ijrobp.2009.04.096
36
37
39
WSHA 2019
12
Otologic Effects of XRT N = 325 patients treated for primary extracranial head and
neck tumors with curative intent who received radiotherapy between 1964 and 2000 (median follow-up, 5.4 years)
Dose incidence varying between 60 Gy to 66 Gy. Total dose to organ seems to be a significant factor though
fractionation and chemo-radiation may contribute to ototoxicities.
40
Bhandare, N., Jackson, A., Eisbruch, A., Pan, C. C., Flickinger, J. C., Antonelli, P., & Mendenhall, W. M. (2010). Radiation therapy and hearing loss. International journal of radiation oncology, biology, physics, 76(3 Suppl), S50–S57. doi:10.1016/j.ijrobp.2009.04.096
Surgical Interventionas initial treatment procedure
o To remove tumor/malignancy (for debulking or for cure)
o To remove affected lymph nodesConsiderations:◦ Concomitant medical conditions◦ Metastasis◦ Goal of Surgery?◦ Post surgical function and rehabilitation◦ Pt and family wishes
41
Side EffectsTrismusNerve Damage resulting in weakness, incoordination, reduced ROM (Short or Long Term)Complete dysfunction of the structureDysphonia/AphoniaDysphagiaPain, infection, etc
42
40
41
42
WSHA 2019
13
Immediate post surgical rehabilitation
Speech intervention and the involvement of a competent, caring SLP may be the most important aspect in a patient’s recovery
Imperative that SLP communicates daily with the surgeons while the pt is inpatient
Frequent SLP intervention (eval/tx) to maximize gains
Focus on functional communication to ensure patient can participate in ongoing
care needs and treatment planning return to PO intake as soon as possible to maintain nutritional needs with
eventual transition to returning to as close to prior function as possible
43Image labeled for reuse: http://www.picpedia.org/highway-signs/b/bias.html
Treatment of No treatmentoThe SLP provides information but not necessarily an opinion regarding which choice is “better” or “best”
oUltimate decision rests with pt with the knowledge that SLP will remain part of their care team regardless of the path they choose◦ There is a role for SLP to continue to work on maximizing
communication and swallowing throughout the continuum of disease progression
oHealthcare, cultural and religious beliefs may play a role
44
https://www.youtube.com/watch?v=hQwlckZyIxE
DR. COHEN (MEDICAL ONCOLOGIST, ASSOCIATE DIRECTOR, TRANSLATIONAL SCIENCE, MOORESCANCER CENTER, PROFESSOR OF MEDICINE) DISCUSSING IMMUNOTHERAPY
47FUTURE VIEWING for INFO: https://www.youtube.com/watch?v=0l7tNg36kc0
43
44
47
WSHA 2019
14
Interdisciplinary HNC Care Team
ENT SurgeonSpeech Language Pathologist
Cancer Care Coordinator (Case manager – RN or Mid Level or Social Worker)Dentist / Oral Surgeon
PCPDietician
Radiation OncologistHematologist/Oncologist (chemo)
Physical TherapistImage labeled for reuse: https://www.piqsels.com/en/public-domain-photo-jrdte
Role of the SLPEvaluation and treatment (pre, during, post)DysphagiaVoice disordersTracheotomy managementPre-surgical counselingPost-surgical / post-treatment rehabilitation
49
Pre-surgical Evaluation and Counseling• Speak with the ENT Surgeons if possible (or have
a copy of their note to refer to surgical plan) • Explain changes to Anatomy, Swallowing,
Speech and Voice• Have models, pamphlets/ brochures, and
significant other/caregiver available during this counseling
• Consider informal/formal evaluation of cognition
50
48
49
50
WSHA 2019
15
Special Considerations for Dysphagia Evaluation Evaluation◦ Frequency of evaluation (best is
ongoing)◦ Role of Quality of Life Indicators
(ongoing)◦ Putting the pieces together on Clinical
/ FEES / MBS
Quality of Life (QoL) Measures
Examined 57 QoL measures from publications 1990-2010
Most commonly used: ◦ European Organisation for Research
and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC QLQ-H&N35)
◦ University of Washington QOL (UW-QOL)
◦ Functional Assessment of Cancer Therapy - Head & Neck cancerFACT-HN40
◦ University of Michigan Head and Neck QOL
◦ MD Anderson Symptom Inventory Head and Neck
Ojo, B., Genden, E. M., Teng, M. S., Milbury, K., Misiukiewicz, K. J., & Badr, H. (2012). A systematic review of head and neck cancer quality of life assessment instruments. Oral oncology, 48(10), 923–937. doi:10.1016/j.oraloncology.2012.03.025
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406264/pdf/nihms-368340.pdf
PROLONG LIFE not DELAY DEATH
“In conclusion, the impact of the diagnosis and treatment of HNC on physical and psychosocial functioning and overall well-being can not be overstated; and the research body on QOL assessment in HNC patients is growing exponentially to address the significant issue of QOL in HNC patients. It is no longer enough to assess mortality and objective morbidity when evaluating treatment alternativesThe patient's QOL is important in the assessment of survival because the goal of optimal patient care is to prolong life not to delay death at the expense of physical and psychosocial suffering. However, the science of QOL assessment has yet to merge with its clinical application.”
• Emphasis is mine• Ojo et al. from previous page
51
52
53
WSHA 2019
16
University of Washington Quality of Life (UW-QoL)
Domains: Physical, Functional, EmotionalResources listed below are open sourceQuestionnaire: https://www.entnet.org/sites/default/files/uw_qol_r_v4.pdfScoring: https://www.entnet.org/sites/default/files/uw_qol_r_v4_scoring.pdfScoring Update: http://www.hancsupport.com/sites/default/files/assets/pages/UW-QOL-update_2012.pdf
Role of Alternative Nutrition in patients with Head and Neck cancer
Alternative nutrition◦ Lab values (Albumin vs. Prealbumin)
PEG / PEJ or Nasogastric Tube ◦Do PEGs cause Dysphagia in HNC ? (Let’s ask Melissa later)
Prophylactic vs. Acute / Urgent placementRole of continued PO intake
ORAL CANCER
ANTICIPATED DEFICITS AND EVALUATION FOCUS:◦ Trismus◦ Swallow ◦ Oral Phase across the board◦ Speech
57
54
55
57
WSHA 2019
17
GLOSSECTOMY
ANTICIPATED DEFICITS AND EVALUATION FOCUS Severity depends on glossectomy surgery (partial
vs. near total):◦ Swallow◦ Oral Phase with focus on bolus control, poor
timing, residue◦ Speech
58
FOM RESECTION +/-RECONSTRUCTION
ANTICIPATED DEFICITS AND EVALUATION FOCUS◦ Swallow◦ Oral Phase with focus on bolus control, poor
timing, residue (from lip, lingual,tongue deficits)◦ Potential for prolonged NPOdecreased muscle
function/inefficiency in pharyngeal swallow◦ Speech
59
BOT/FAUCIAL PILLAR/TONSIL
ANTICIPATED DEFICITS AND EVALUATION FOCUS◦ Swallow◦ Oral Phase related to containment/bolus control
and timing◦ Pharyngeal Phase deficits possible◦ Speech not nearly as impacted
60
58
59
60
WSHA 2019
18
PALATE/VELUM/SINUS CANCER
ANTICIPATED DEFICITS AND EVALUATION FOCUS◦ Swallow◦ Oral Phase related to containment/bolus control◦ Nasal Regurgitation ◦ Fitting for obturator / palatal lift◦ Pharyngeal Phase deficits possible (residue if
reduced ability to create drive on tail of bolus)◦ Speech deficits can range from non-existent to
severe
61
PHARYNGEAL/HYPOPHARYNGEAL CANCER ANTICIPATED DEFICITS AND EVALUATION FOCUS
◦ Swallow◦ Pharyngeal Phase deficits ◦ Speech deficits much less likely
62
LARYNGEAL CANCER
ANTICIPATED DEFICITS AND EVALUATION FOCUS◦ Impacts swallowing to varying degrees◦ Dependent on treatment choice and size of
tumor◦ Impacts communication to varying degrees◦ Again dependent on treatment choice and
tumor◦ Evaluation focuses on both voice and swallowing
initially and continues PRN
63
61
62
63
WSHA 2019
19
TREATMENT CONSIDERATIONS:
◦ ROM exercises / Prophylactic treat
◦ Speech therapy to address precision in articulation
◦ Maneuvers & Strategies (Diet Modification, Postures, use of assistive devices)
◦ Evidence Based Dysphagia Intervention to maximize current function and potential for return to maximum post treatment function
◦ More on treatment from Melissa and Joy tomorrow
Brief Introduction to Laryngectomy
67
Laryngectomee vs Laryngectomy
Images from Atos Medical
64
66
67
WSHA 2019
20
Pre-Laryngectomy
1. Breathing occurs through nose and mouth2. Any dust or particles get trapped in your nose and
coughed/sneezed out3. Nose and mouth moisten, filter and heat air before it
enters lungs4. Nose and mouth are connected to both esophagus
and trachea5. When food, liquid or saliva are swallowed, each can
go down the “right” pipe (esophagus) or “wrong pipe” (trachea)
6. Coughing results in mucus/saliva coming up into throat which is subsequently swallowed down into stomach
7. Vocal Cords have multiple jobs:1. close during swallowing to protect food or liquid
from entering lung2. Close off for breat holding
8. Articulators: tongue, teeth, roof of mouth and lips turn the sound into words
Images from Atos Medical
Post Laryngectomy
1. No longer breathe through nose and mouth2. Vocal cords are removed3. Breathe directly into trachea through stoma
(opening) in the neck4. Stoma is a permanent opening5. Filtering, heating and moistening of air no longer
occur6. Mouth no longer connected to the airway, so
during swallowing, food can no longer go down the wrong pipe
7. During coughing, mucus will come out of stoma8. To breath hold, the stoma must be covered9. An alternative sound source to speak (AL, TEP,
Esophageal Speech)10.Swimming and playing wind instruments will be
difficult
Images from Atos Medical
70
Total Laryngectomy
Before Laryngectomy After Laryngectomy
Images from Atos Medical
68
69
70
WSHA 2019
21
TerminologyStoma: aka tracheostoma. It is the hole in the neck made by redirecting the windpipe forward and creating a permanent opening. After the surgery, air will move in and out of the lungs through the stoma TEP: Tracheoesophageal Puncture and Prothesis(TE) Fistula: hole (puncture) where the TE Prosthesis lies in the common party wall between the trachea and the esophagus
71
Functional ChangesSwallowingHumidificationSecretion ManagementShoweringSwimmingEmergency CareSexual functioning
72
Pre-operative Education and Evaluation: Standard of Care
Establish rapportAlways ask, “What has the doctor told you about your surgery?”General overview of impact of total laryngectomy on function:
Pulmonary and CommunicationProvide overview of rehabilitation processPulmonary CommunicationSwallowing Initiate a functional communication alternativeLaryngectomee visitation if appropriate
CE001-05.13.2019
Images from Atos Medical
71
72
73
WSHA 2019
22
Pre-operative Education, Counseling and ScreeningEducation and CounselingAnatomical Changes, Breathing, Swallowing, Communication, Self-Care Requirements
ScreeningCognition, vision, dexterity, support system, esophageal factorsPatients receive educational materialsPossible peer laryngectomy counseling/meetingTentative d/c plans are identified
CE001-05.13.2019
Images from Atos Medical
Preop Counseling and Its Affect on Length of Stay and Readmissions
Counseling session by SLP and surgery performed by high volume surgeon reduces length of stay (LOS)
d/c to rehab facility actually increases risk of ED visit (Shenson et al ,2017)
“The best care for the head and neck patient is likely given by a team of treating members who address both the oncologic and the functional challenges of treatment“ (Dr. Liu, commentary on Shenson et al, 2017)
CE001-05.13.2019
Images from Atos Medical; purchased from iStock
The Pre/Post TL Communication and Pulmonary Plan of Care
Short-term and long-term communication options: Timing or puncture planned preoperativelyPulmonary rehabilitation: Begins in the ORAccess to supplies: Planning begins preoperatively
CE001-05.13.2019
74
75
76
WSHA 2019
23
Communication OptionsMust involve the patientNot limited to just one optionEducate pt on all forms of alaryngealvoice restoration (i.e. artificial larynx- AL, TEP, esophageal speech) Not all patients are a candidate for a TEPImportant that the patient and healthcare team are on the same page
Post-Operative Communication GoalsReplace: Independent functional form of
communicationReduce: Patient dependence on clinicianImprove: Social engagement and QOLEnable: Patient to engage in care and
management of any devices required for communication
CE001-05.13.2019
Patient Goals
Able to be heard and understood by everyoneAchieve social acceptanceAchieve self acceptanceAchieve hands free with TEP
CE001-05.13.2019
Images from Atos Medical
77
78
79
WSHA 2019
24
In-Hospital Communication OptionsGesturesAugmentative communication Writing (Boogie Board®, dry erase boards)Smartphone applicationsElectrolarynxTEP (only used when cleared by MD ~ POD 14)
CE001-05.13.2019
What we covered…
Head and Neck Cancers
Treatment Options
Deficits by Cancer Site
Interdisciplinary HNC Care Team
SLP Scope and Role
Quality of Life (QoL)
Laryngectomy◦ Anatomical Changes◦ PreOp Evaluation and Counseling
81
THANKS!
Contact Info
83
Bridget Guenther(505) 484-8001Atos Medical, [email protected]
80
81
83